Question explored with the scientific record
Conversation so far
- 1 Muscle tension dysphonia + a private exchange
- 2 What other treatments besides voice exercises help MTD?
- 3 How can we tell MTD from spasmodic dysphonia or dystonia?
Answered on this page ↓
How can we tell MTD from spasmodic dysphonia or dystonia?
The single best separator is task specificity: spasmodic dysphonia breaks down on connected speech but holds up on a sustained vowel, while muscle tension dysphonia is bad on both.
That is the one clean signal in this evidence. In 36 patients with adductor spasmodic dysphonia, severity was worse in connected speech (6.22) than on a sustained vowel (4.8) [1]. In 45 patients with muscle tension dysphonia, the two were nearly identical, 5.98 versus 5.86 [1]. So ask the person to hold a steady "ahh" and then read a sentence. If the voice is strained and broken only in running speech, think dystonia. If it is tight in both, think MTD.
| Feature | Spasmodic dysphonia | Muscle tension dysphonia |
|---|---|---|
| Connected speech vs sustained vowel | Worse in speech [1] | About equal [1] |
| Voice quality score (DSI) | Not reported | -0.96, vs 3.9 healthy [2] |
| Brain activity on phonation | Not reported | Altered patterns [2] |
| Botox response | ~2 in 3 improved [6] | Not tested here |
Dystonia is a neurological disorder, not a habit. It can run in families through genes like THAP1 [5], and it shows up as altered brain connectivity in focal dystonia [4]. MTD is a diagnosis of exclusion: the vocal folds look normal but the muscles overwork, and it can persist even after the mechanical cause is fixed [3]. The brain imaging in MTD shows altered activation during phonation, which supports a central component rather than pure overuse [2].
What this evidence cannot do is give you a bedside test that separates them with certainty. The task-specificity finding is one study, and it is a group average, not a rule for one throat. The definitive test is laryngoscopy with a specialist who examines the larynx during connected speech, and that is not in these records.
My call: use the sustained-vowel-versus-speech contrast as your first clue, then get a laryngologist to look during speech before anyone injects anything. Confidence: moderate on the task-specificity signal, low on any single test settling it.
Sources used 6
-
Task Specificity in Adductor Spasmodic Dysphonia Versus Muscle Tension Dysphonia
This study investigates the diagnostic value of 'task specificity' in differentiating adductor spasmodic dysphonia (ADSD) from muscle tension dysphonia (MTD) by comparing dysphonia severity ratings during connected speech and sustained vowel productions.
DOI: 10.1097/01.mlg.0000154739.48314.ee -
Brain Activity During Phonation in Women With Muscle Tension Dysphonia: An fMRI Study
This fMRI study investigates brain activity during phonation in women with muscle tension dysphonia (MTD) compared to healthy controls, revealing altered brain activation patterns that may contribute to laryngeal tension and vocal hyperfunction in MTD patients.
DOI: 10.1016/j.jvoice.2017.03.010 -
Features of Muscle Tension Dysphonia before and after Correction of Unilateral Vocal Cord Paralysis
A retrospective longitudinal study of 86 patients with unilateral vocal cord paralysis (UVCP) undergoing successful surgical correction found that laryngeal muscle tension patterns (MTPs) largely persisted after medialization, despite improved glottal closure and vocal fatigue i…
DOI: 10.1177/000348940711600208 -
Isolated focal dystonia
This Neurology commentary discusses Norris et al.'s resting-state fMRI study of 58 patients with isolated focal dystonia and 47 controls, reporting regional reductions in functional connectivity within the striatum and between sensorimotor cortex and the ventral intraparietal ar…
DOI: 10.1212/WNL.0000000000010818 -
Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study
This study identifies two novel mutations in the THAP1 gene associated with early-onset generalized dystonia and spasmodic dysphonia in a cohort of patients, highlighting the genetic underpinnings of DYT6 dystonia.
DOI: 10.1016/S1474-4422(09)70083-3 -
Botulinum toxin treatment for spasmodic dysphonia (adductor laryngeal dystonia) Experience with 31 patients
Botulinum toxin injections into the vocalis muscles yielded substantial voice improvement in about two-thirds of patients with adductor laryngeal dystonia, with effects lasting 2–28 months and common transient breathy voice and mild dysphagia.
DOI: meta/10.3109/14015439409102354